Dopamine plays an important role in the pathogenesis of hypertension by regulating epithelial sodium transport, vascular smooth muscle contractility and production of reactive oxygen species and by interacting with the renin-angiotensin and sympathetic nervous systems. Dopamine receptors are classified into D 1 -like (D 1 and D 5 ) and D 2 -like (D 2 , D 3 and D 4 ) subtypes based on their structure and pharmacology. Each of the dopamine receptor subtypes participates in the regulation of blood pressure by mechanisms specific for the subtype. Some receptors regulate blood pressure by influencing the central and/or peripheral nervous system; others influence epithelial transport and regulate the secretion and receptors of several humoral agents. This review summarizes the physiology of the different dopamine receptors in the regulation of blood pressure, and the relationship between dopamine receptor subtypes and hypertension.
INTRODUCTION
Essential hypertension affects 25 % of the adult population and constitutes a major risk factor for stroke, myocardial infarction, heart failure and kidney failure [1] [2] [3] . The cause(s) is complex, because both genetic and environmental factors participate in the pathogenesis of hypertension [4] [5] [6] [7] [8] [9] . It has been estimated, however, that 30-50 % of essential hypertension is heritable. Approx. 30-35 % of subjects with normal BP (blood pressure) are salt-sensitive; in hypertensive patients, this percentage is as high as 50-70 % [10] [11] [12] . Because the kidney is important in the long-term regulation of BP and is the major organ involved in the regulation of sodium homoeostasis, many studies have focused on the abnormal renal handling of salt in the pathogenesis of hypertension. The proximal tubule and medullary thick ascending limb of Henle are pre-eminent in the overall ability of the kidney to regulate sodium balance [11, [13] [14] [15] [16] . Indeed, several studies have shown that human essential hypertension is associated with increased sodium transport in the renal proximal tubule [13, 15] . Dopamine, produced locally and independent of innervation, is now recognized as an important regulator of systemic BP [1, 4, 5, 14] . In the periphery, this BP regulation is achieved by direct action on arterial and venous vessels to alter renal haemodynamics, and on fluid and electrolyte balance via effects on renal and gastrointestinal epithelial ion transport [1, 4, 5, 14] . The effects of dopamine, in mammals, are mediated by five dopamine receptor subtypes (Figure 1 ). These five receptor subtypes, identified to date by molecular cloning, differ in their primary structures and show distinct affinities for dopamine receptor agonists and antagonists. Their
Figure 1 Dopamine receptor subtypes and their roles in regulation of BP
The solid lines indicate the interaction based on direct evidence, whereas the broken lines shows an interaction based on indirect evidence. current classification is based on the functional properties of these receptors. The D 1 -like receptors are composed of the D 1 and D 5 receptor subtypes, which couple to the stimulatory G-proteins G s and G olf and activate adenylate cyclase activity to increase cytosolic cAMP levels. The D 2 -like receptors are composed of the D 2 , D 3 and D 4 receptor subtypes, which couple to the inhibitory G-proteins G i and G o and modulate ion channel activity and/or inhibit adenylate cyclase activity [1, 4, 5, 14] . The affinity of dopamine for its receptors ranges from the low nanomolar to the low micromolar level. At higher concentrations, α-and β-adrenergic and serotonin receptors are occupied. Although circulating concentrations of dopamine (picomolar range) are not sufficiently high to activate dopamine receptors, a high nanomolar to micromolar range can be attained in dopamine-producing tissues [1, 4, 5] .
Abnormal sodium metabolism is frequently encountered in hypertension [1, 13, 15] . Several forms of monogenic hypertension are caused by increased sodium transport in the distal nephron [17] . All of the dopamine receptor subtypes have been shown to regulate, directly or indirectly, renal sodium transport (in the proximal and distal nephron) and BP [1, 4, 5, 14] . The aim of this review is to present experimental evidence that has led to the conclusion that dopamine is a major regulator of sodium metabolism by itself, or by interaction with other BPregulating systems.
DOPAMINE METABOLISM
Dopamine is synthesized not only in noradrenergic and dopaminergic nerves, but also in non-neural tissues, such as the kidney and gastrointestinal tract. The synthesis of dopamine differs between neurons and epithelial cells. Neurons express tyrosine hydroxylase, which converts tyrosine into l-DOPA, and AADC (aromatic amino acid decarboxylase), which decarboxylates l-DOPA to dopamine [18, 19] . In contrast, jejunal and renal proximal tubule cells lack tyrosine hydroxylase, but highly express AADC. l-DOPA in the circulation or filtered by the renal glomeruli is transported into the renal proximal tubule via a sodium-independent and pH-sensitive type 2 Ltype amino-acid transporter [20] . Sodium loading causes an increase in the uptake of l-DOPA and, hence, the synthesis of dopamine. In addition to l-DOPA, 3-Omethyldopa may also serve as a precursor of dopamine in the renal proximal tubule [21] .
Unlike neurons, renal proximal tubule cells do not express dopamine β-hydroxylase and, therefore, synthesized dopamine is not converted into noradrenaline (norepinephrine) [1, 4, 5] . Dopamine produced in the proximal tubule is not stored, but transported both to the basolateral membrane and into the tubular lumen where it can act on receptors locally and in more distal nephron segments.
Decreased renal dopamine synthesis and hypertension
Decreased renal synthesis of dopamine may be involved in the pathogenesis of essential hypertension in some human subjects [22] . Some salt-sensitive subjects, with or without hypertension, do not increase renal dopamine production in response to a salt or protein load [23] [24] [25] [26] . However, a decreased renal production of dopamine does not explain the impaired function of endogenous dopamine in many cases of essential hypertension. Urinary dopamine and dopamine metabolites are actually increased in young patients with essential hypertension [27, 28] . The urinary excretion of dopamine is not decreased in the SHR (spontaneously hypertensive rat) or in the Dahl salt-sensitive rat compared with their normotensive controls [29] [30] [31] . Increasing renal dopamine production in SHRs does not enhance the ability of D 1 -like agonists to inhibit renal cortical NHE3 (Na + /H + exchanger 3) activity or increase sodium excretion to the same degree as observed in WKY (Wistar-Kyoto) rats [32] .
D 1 RECEPTOR
Previous studies have shown that stimulation of the renal D 1 -like receptor is associated with diuresis and natriuresis that is not dependent on an increase in renal blood flow [33] [34] [35] , although activation of D 1 -like receptor in resistance arteries does induce vasodilation [36, 37] . The D 1 [36, [38] [39] [40] and D 5 [41] [42] [43] In the kidney, D 1 receptor protein is expressed in the juxtaglomerular cell, proximal tubule, distal convoluted tubule, macula densa, cortical collecting duct and renal vasculature. In the juxtaglomerular cell, the receptor is predominantly located in the arteriolar smooth muscle layer within cytoplasmic granules shown previously to contain renin, but not in glomeruli. In the proximal tubule, staining is localized both to the brush-border and basolateral membranes [38, 44, 45] . The D 1 receptor is expressed in the tunica media of pial, renal and mesenteric artery branches [46, 47] . An in situ hybridization histochemistry study has also shown D 1 receptors in the tunica media of the aorta, common carotid artery, vertebral artery, pulmonary artery and superior vena cava of adult male Sprague-Dawley rats [48] .
The gastrointestinal tract is another site in which the D 1 receptor regulates sodium transport: D 1 receptors are expressed in the oesophagus, gastroesophageal junction, stomach, pylorus, small intestine (duodenum and jejunum) and colon. The receptor is distributed in epithelial and muscle layers, blood vessels and lamina propria cells in different gastrointestinal regions [49, 50] .
Physiological role of peripheral dopamine receptors
Natriuretic and diuretic effects of D 1 receptor activation Endogenous renal dopamine is a major physiological regulator of renal sodium excretion. During conditions of moderate sodium balance, more than 50 % of renal sodium excretion is regulated by D 1 -like receptors [4, 5, 33, 35, 51] . Although the natriuresis induced by exogenously administered D 1 -like receptor agonists is caused both by an increase in renal blood flow and a decrease in sodium transport, endogenous dopamine can exert its natriuretic effect independent of renal blood flow [33] . The D 1 receptor increases cAMP production to a greater extent than the D 5 receptor in renal proximal tubule cells [52] . Therefore it is possible that the natriuretic effect of dopamine is due mainly to the D 1 receptor.
The natriuretic and diuretic effects of the D 1 receptor are dependent on sodium balance. In sodium-depleted states, D 1 -like receptor-mediated natriuretic effects (mainly via the D 1 receptor) may not be evident, whereas, during sodium-replete states, D 1 -like receptor effects become apparent [5, 6, 13, 14, 33, 35, 51] . There is even a synergistic action between D 1 -like and D 2 -like receptors to increase renal sodium excretion [35, 37, 53] . The natriuretic effect of the D 1 receptor is caused by both an increase in renal blood flow and inhibition of sodium transport. The D 1 receptor can inhibit NHE3 [54, 55] , the Na + -P i cotransporter [56] and the Cl − /HCO 3 − exchanger [57] at the luminal membrane and Na + /K + ATPase [58, 59] and the Na + -HCO 3 − cotransporter [60] at the basolateral membrane [5, 6, 13, 14] . There is direct evidence for the natriuretic effect of D 1 receptors in vivo: infusion of D 1 receptor antisense oligodeoxynucleotides directly into the renal interstitial space for 1 week decreases both D 1 receptor expression and sodium excretion without influencing D 5 receptor expression [61] . Moreover, chronic administration of the long-acting D 1 receptor antagonist ecopipam increases BP in humans [62] . Although BP did not increase in these mice [61] , disruption of the D 1 receptor in mice does lead to the development of hypertension [63] . The DRD1 gene polymorphism A−48G (where DRD1 encodes the D 1 receptor) is also associated with essential hypertension [64] .
Effect of D 1 receptor activation on resistance vessels Dopamine, at low concentrations, dilates resistance arteries via D 1 -like receptors [36, 65] . However, the effect of D 1 -like receptors on vascular tone may vary depending upon the arterial segment. For example, a D 1 -like receptor agonist increases the vascular tone of the rat tail artery [66] ; in other vessels, including the renal artery, D 1 -like receptors are vasodilatory [34, 36, 65, 67, 68] . The vasorelaxant effect of dopamine in the rabbit pulmonary artery has been reported to be both endothelium-dependent and -independent [69] . However, in the mesenteric artery, we have found that the vasodilatory effect of the D 1 receptor agonist is endothelium-independent. Simultaneous stimulation of D 1 and D 3 receptors causes a vasorelaxation that is additive rather than synergistic [36, 70] . The vasorelaxant effect of the D 1 receptor is enhanced by calcium channel blockade with nifedipine, indicating that the calcium channel is involved in the vasodilatory effect of D 1 receptors [36, 70] .
Effect of D 1 receptor activation in the gastrointestinal tract Dopamine may also participate in the regulation of bicarbonate, chloride and sodium transport in the gastrointestinal tract, an action that, as in the kidney, is modulated by sodium intake [39, [71] [72] [73] . In 20-dayold rats, Na + /K + ATPase activity is reduced during a high-salt diet. This inhibition is caused by endogenously formed dopamine, as this phenomenon is abolished by a dopamine synthesis blocker [71] . The dopamine receptor subtype involved is probably a D 1 -like receptor, because D 2 -like receptors increase transport in the ileum [74] . Both D 1 -like receptors (D 1 and D 5 ) probably decrease sodium transport in the intestine.
D 1 receptor and hypertension

Impaired renal D 1 receptor and hypertension
Numerous studies have demonstrated that the natriuretic effect of D 1 receptor stimulation is caused both by an increase in renal blood flow and inhibition of sodium transport [4] [5] [6] 13, 14, 34, 35] . In humans with essential hypertension and rodents with genetic hypertension (SHRs and Dahl salt-sensitive rats), D 1 -like receptor agonist-mediated natriuretic and diuretic responses are impaired [37, [75] [76] [77] . The ability of the D 1 -like receptors to inhibit renal proximal sodium reabsorption is also impaired in humans with essential hypertension [34] . The decreased ability of D 1 -like receptor agonists to inhibit renal sodium transport in rodent genetic hypertension is caused by diminished D 1 -like receptor inhibition of NHE3, the Cl − /HCO 3 − exchanger, the Na + -HCO 3 − cotransporter and Na + /K + ATPase activities [1, 5, 6, 13, 14, 32, 57, 60, 77, 78] . Further studies have shown that the impaired inhibitory effects of D 1 -like receptor on epithelial sodium transport is due to an uncoupling of the D 1 -like receptor from its G-protein/effector complex [79] [80] [81] . The uncoupling is receptor-specific, organ-selective and nephron-segment-specific, precedes the onset of hypertension and co-segregates with the hypertensive phenotype [5, 6] . The defective transduction of the renal dopaminergic signal is caused by activating variants of GRK4 [encoding GPCR (G-protein-coupled receptor) kinase type 4], especially R65L, A142V and A486V variants [81] . We have reported [82, 83] , with subsequent confirmation by others [84, 85] , that GRK4, a gene that regulates a limited number of GPCRs, has variants (R65L, A142V and A486V) that are associated with essential hypertension in several ethnic groups (Caucasians, Chinese and Japanese). In Ghanaians, the combination of GRK4 65L and ACE I/D (angiotensinconverting enzyme insertion/deletion), is associated with essential hypertension [86, 87] . The GRK4 locus on human chromosome 4p16.3 is linked with hypertension [88] [89] [90] [91] . The increase in BP with age in white and African Americans is associated with GRK4 65L [92] and the increase in BP and decrease in sodium excretion with mental stress is associated with GRK4 65L in adolescent African Americans [93] . GRK4 486V, by itself [82] or in conjunction with GRK4 65L and GRK4 142V [83] , is associated with salt sensitivity. Indeed, the presence of three or more GRK4 variants impairs the natriuretic response to dopaminergic stimulation in humans [83] .
In genetically hypertensive rats, renal inhibition of GRK4 expression, which is increased, ameliorates the hypertension [94] . In mice, overexpression of GRK4 variants causes hypertension either with or without salt sensitivity according to the variant. GRK4 gene variants, by preventing the natriuretic function of the dopaminergic system, may be a cause of salt sensitivity [81] .
Impaired D 1 receptor arterial function and hypertension
In hypertensive states, the renal and non-renal vasodilatory effects of D 1 -like receptors may or may not be impaired [34, 95] . There are, however, reports of impaired renal vasodilatory effects of a D 1 -like receptor agonist in humans with essential hypertension [96] and in SHRs [65, 97] . Indeed, the ability of D 1 -like receptors to stimulate adenylate cyclase in renal arteries is impaired in SHRs [65] . We have also reported an impaired ability of D 1 receptors to dilate mesenteric arteries of SHRs [70] . There is an additive vasodilatory effect of D 1 and D 3 receptors in normotensive WKY rats that is no longer apparent in SHRs [36, 70] .
Impaired D 1 receptor gastrointestinal tract function in hypertension
In obese and lean Zucker rats, basal Na + /K + ATPase activities in jejunum are different and are dependent on salt intake. The difference in basal Na + /K + ATPase activity could be due to different dopamine levels. In addition, the D 1 -like receptor agonist SKF 38393 inhibits jejunal Na + /K + ATPase activity in obese Zucker rats on high-salt intake, but fails to inhibit it in lean Zucker rats [98] . Different effects of dopamine receptor stimulation on jejunal Na + /K + ATPase are also found in SHRs and WKY rats. Basal jejunal Na + /K + ATPase activity is higher in SHRs than in WKY rats, and SKF 38393 (a D 1 -like receptor agonist) inhibits jejunal Na + /K + ATPase activity in WKY rats, but not in SHRs [99] . 
Physiological role of D 5 receptors
Diuretic and natriuretic effects in kidney
As stated above, activation of the D 1 -like receptor in kidney induces diuresis and natriuresis. However, due to a lack of a specific D 5 receptor agonist, the extent to which the D 5 receptor contributes to D 1 -like receptor-mediated diuretic and natriuretic effects is not known. Using antisense oligonucleotides to silence either the D 1 or the D 5 receptor, we found that the increase in cAMP levels following D 1 -like receptor stimulation is due mainly to the D 1 receptor relative to the D 5 receptor (80 % compared with 20 %) [51] . Because cAMP, via PKA (protein kinase A), is involved in the inhibition of sodium transporters in the proximal tubule, we have presumed that the major D 1 -like receptor regulating sodium transport is the D 1 receptor. However, D 1 -like receptormediated sodium transport can be independent of PKA activation [55] . Therefore the relative contribution of the D 1 or the D 5 receptor to renal sodium transport needs to be determined. Indeed, in D 5 −/− mice, a high-salt diet increases BP further, suggesting that the D 5 receptor in the kidney plays an important role in the control of BP, in part by regulating sodium transport [104, 105] .
The effects of the D 5 receptor on renal proximal tubular sodium reabsorption could be partially ascribed to an interaction between D 5 and AT 1 Vasodilatory and antiproliferative effects in the artery [36, 65, 68, 70, [111] [112] [113] , increases renal blood flow and decreases BP [67, 95] . We found that the vasodilatory effect of the D 1 -like receptor is endothelium-independent and is enhanced by calcium channel blockade [36] . Co-stimulation of D 1 -like and D 3 receptors has an additive effect [70] ; however, it is not known which D 1 −/− mice is antagonized by a non-NMDA (Nmethyl-d-aspartate) receptor antagonist that crosses the blood-brain barrier, whereas a non-NMDA receptor antagonist that does not cross the blood-brain barrier has no effect on BP. This indicates that non-NMDA receptors are involved in the signal transduction pathway of D 5 receptors in the brain [105] . However, the adrenergic nervous system is generally thought involved to be in acute regulation of BP [117] . In subsequent and, as yet unpublished studies, we have found that the chronic regulation of BP in D 5 −/− mice involves the AT 1 receptor (L.D. Asico, Z. Yang, C. Zeng and P.A. Jose, unpublished work).
The D 5 locus is not linked to hypertension in Dahl salt-sensitive rats [118] , and mutations of the DRD5 gene (encoding the D 5 receptor) are not found in SHRs. However, the locus of DRD5, 4p15.1-16.1 [88] [89] [90] [91] , and its pseudogenes, 1q21.1 and 2p11.1-p11.2 [119] , have been linked to human essential hypertension [120, 121] . Moreover, humans have single nucleotide polymorphisms in the DRD5 gene with diminished D 5 receptor function [122] .
D 3 RECEPTOR
The DRD3 gene (encoding the D 3 receptor), located in chromosome 3q13.3, first cloned from rat brain, is also expressed in peripheral neural and non-neural tissues [123] [124] [125] [126] [127] [128] . O'Connell et al. [128] reported that the D 3 receptor is expressed in renal proximal and distal convoluted tubules, cortical collecting ducts, glomeruli and renal blood vessels. Immunohistochemistry and immunogold electron microscopy have shown that the D 3 receptor is expressed predominantly in the apical and subapical areas of proximal and distal tubules and in glomerular podocytes [128, 129] . D 1 -like receptors are located mainly in the tunica media, whereas D 2 -like receptors are located primarily in the intima and adventitia [46, 130] . In the rat renal artery, the D 3 receptor is located at both pre-junctional (adventitia) and post-/extra-junctional sites (tunica media) [46, 130] . In contrast, in the rat mesenteric artery, we found that the D 3 receptor is expressed in both the tunicae intima and media [36, 70] .
Physiological role of D 3 receptors
Effect of the D 3 receptor on renal function
Most in vivo studies have shown that the natriuretic effect of dopamine is exerted mainly via D 1 -like receptors [4, 5, 35, 131, 132] . The effect of D 2 -like receptors, independent of D l -like receptors, on sodium transport and/or natriuresis has ranged from antinatriuresis, to no effect, to natriuresis [35, 133, 134] . It is possible that these discrepant effects are related to the use of drugs that have poor selectivity to a specific D 2 -like receptor subtype [134] [135] [136] . That D 3 receptors can mediate natriuresis is supported by the decreased ability of D 3 −/− mice to excrete an acute saline load [124] . 7-OH-DPAT [R(+)-7-hydroxy-2-(N,N-di-n-propylamino)tetraline], a D 3 receptor agonist with preferential selectivity for D 3 over D 2 and D 4 receptors [135] [136] [137] , decreases sodium transport. PD128907, a selective D 3 receptor agonist with 120-fold selectivity over the D 2 receptor, infused directly into the renal artery in WKY rats and SHRs fed a high-salt diet dose-dependently increases fractional sodium excretion in WKY rats (but not in SHRs) [138] . The renal effects of D 3 receptor activation are mediated by actions on post-junctional glomerular and tubular receptors and pre-synaptic modulation of noradrenaline release, because renal denervation attenuates the renal effects of 7-OH-DPAT [123] . These studies described above show that the D 3 receptor can exert a natriuretic effect, independent of D 1 -like receptors. The D 3 receptor can inhibit NHE3 activity via an inhibitory G-protein Gα i3 /PKC (protein kinase C)-mediated process [139] . The D 3 receptor can be linked to inhibition of adenylate cyclase activity, especially in the presence of the adenylate cyclase V isoform [140] . The natriuretic effect of D 1 -like receptors can be augmented by D 2 -like receptors [4, 35, 53] . In vivo and in vitro studies have suggested that a D 2 -like agonist, in concert with a D 1 -like agonist, can synergistically act to decrease Na + /K + ATPase and NHE3 activity in renal proximal tubule cells and brain striatal cells and to inhibit sodium and phosphate cotransport in opossum kidney cells [141] [142] [143] [144] . However, it is not known which dopamine receptor subtypes are involved in this synergistic action. In the rat kidney, the major D 2 -like receptor in renal proximal tubules is the D 3 receptor [128, 136] [136, 147] . Under states of increased renal vascular resistance, post-junctional D 3 receptors produce vasodilation [36] . Thus we have reported that D 3 receptor activation in the isolated third generation of rat mesenteric vessels produces vasodilation [36, 70] and not vasoconstriction. Our studies show that, in the isolated relaxed mesenteric artery, two different D 3 receptor agonists, PD128907 and 7-OH-DPAT, have no effect on basal vascular contractility [36, 70] . However, in noradrenaline-or high-potassiumpre-constricted vessels, both PD128907 and 7-OH-DPAT induce vasorelaxation. The vasodilatory effect of D 3 receptors may also involve potassium channels (smalland/or large-conductance calcium-activated potassium channels) [36, 148] The vasorelaxant effect of dopamine in the rabbit pulmonary artery has been reported to be both endotheliumdependent and -independent [69] . In our studies, in spite of the presence of D 3 receptors in the intima, we found that the vasodilatory effects of D 1 and D 3 receptor agonists are endothelium-independent. The function of the D 3 receptor in endothelial cells is not clear, but D 3 receptors have cell-protective properties [70] .
Role of D 3 receptors in hypertension
Sodium excretion
Association between DRD3 gene polymorphisms (− 707 G/C, Ser9Gly and Ala17Ala) and BP have not been reported [149] [150] [151] , but the chromosome locus of the DRD3 gene (3q13.3) has been linked to human essential hypertension [152, 153] . Disruption of the Drd3 gene in mice produces renin-dependent hypertension with an impairment in sodium excretion [124] . Dahl salt-resistant rats on high-, but not on normal-, sodium diet and chronically treated with a highly selective D 3 receptor antagonist, BSF 135170, have high BP [147] . Therefore D 3 receptor deficiency may be important in the development of salt-sensitive hypertension.
7-OH-DPAT induces natriuresis in Dahl salt-sensitive rats fed a normal-sodium diet, but not in hypertensive Dahl salt-sensitive rats on a high-sodium diet. The diminished functional response to D 3 receptor stimulation in the hypertensive Dahl salt-sensitive rat is associated with decreased 3 [H]-7-OH-DPAT binding to renal membrane protein [147] . We have studied the renal effects of another selective D 3 receptor agonist, PD128907, infused directly into the renal artery of WKY rats and SHRs fed a high-salt diet. PD128907 dosedependently increases fractional sodium excretion in WKY rats, an effect that is blocked by the D 3 receptor antagonist GR103691. No such effect is observed in SHRs [138] . As stated earlier, D 1 -like and D 2 -like receptors synergistically increase sodium excretion in WKY rats, but not in SHRs [35, 37, 53] . The impaired D 1 -like and D 2 -like receptor interaction in SHRs is not caused by alterations in the coding sequence of the D 3 receptor [37] . However, compared with WKY rats, D 3 receptor protein expression is lower [37, 154] and D 3 receptor phosphorylation (C. Zeng, L.D. Asico and P.A. Jose, unpublished work) is higher in renal cortical and brush border membranes from SHRs. These may, in part, explain the impaired natriuretic effect of D 3 receptors and impaired interaction between D 2 -like and D 1 -like receptors; the function of the latter is also impaired in genetic hypertension [1, 5, 6, 13, 14, 32, 57, 60, [77] [78] [79] [80] [81] .
Vascular D 3 receptors in hypertension
In isolated mesenteric arterial rings, D 3 receptor-agonistinduced vasorelaxation is similar in WKY rats and SHRs, except at very high concentrations; this effect is via the D 3 receptor, because it is blocked by the D 3 receptor antagonist U99194A. Whereas pre-treatment of mesenteric arteries with PD128907 enhances the vasorelaxant effect of fenoldopam in WKY rats, no additional vasorelaxant effect is observed in SHRs [36, 70] , suggesting that arterial D 1 and D 3 receptor interaction is qualitatively and quantitatively different between WKY rats and SHRs.
Aberrant interaction with AT 1 receptors
The dopaminergic and renin-angiotensin systems interact to regulate renal function [108, 109] . D 1 -like receptor agonists can antagonize the stimulatory effect of AngII, acting via AT 1 receptors, on renal proximal tubular sodium transport [108] . D 2 -like receptors can also interact with the renin-angiotensin system [124, 155] . The stimulatory effect of AngII on Na + /K + ATPase activity can be inhibited by prior treatment with the D 2 -like receptor agonist bromocryptine [156] . However, it is not known which of the three dopamine subtypes, D 2 , D 3 or D 4 , is engaged in this physiological action. Our previous study has shown that D 3 −/− mice have a decreased ability to excrete an acute sodium load [124] , and AT 1 receptor expression is higher in renal cortical membranes from D 3 −/− mice than in those from control wild-type mice [157] . Further studies indicate that activation of the D 3 receptor decreases AT 1 receptor expression in a doseand time-dependent manner in renal proximal tubule cells from normotensive rats [158] . Therefore we surmise that one of the D 2 -like receptors that interacts with the AT 1 receptor in rat renal proximal tubule cells is the D 3 receptor. The mechanism for the inhibitory effect of the D 3 receptor on AT 1 receptor expression has not been studied; however, the D 2 receptor, another member of the D 2 -like receptor family, has been reported to decrease gene expression by translational and/or post-translational protein-stabilizing modifications [159] . It is possible that the D 3 receptor regulates AT 1 receptor expression by similar mechanisms. D 3 and AT 1 receptors can also directly interact with each other in renal proximal tubule cells from normotensive rats: D 3 and AT 1 receptors colocalize (by confocal microscopy) and co-immunoprecipitate [146] . The interaction between D 3 and AT 1 receptors in renal proximal tubule cells is different between WKY rats and SHRs [158] . For example, the stimulatory effect of the D 3 receptor agonist PD128907 on D 3 receptor expression is no longer evident in renal proximal tubule cells from SHRs. Moreover, the D 3 receptor decreases AT 1 receptor levels in renal proximal tubule cells from WKY rats, whereas D 3 receptor stimulation increases AT 1 receptor expression in SHRs [158] . Basal D 3 /AT 1 receptor coimmunoprecipitation in renal proximal tubule cells is greater in WKY rats than in SHRs, and D 3 receptors decrease, rather than increase, their co-immunoprecipitation in SHR cells after D 3 receptor stimulation [158] . The impaired natriuretic effect of the D 3 receptors in D 3 −/− mice [124] and in SHRs [138] may be, in part, related to impaired D 3 receptor inhibitory regulation of the AT 1 receptor.
D 2 RECEPTOR
The D 2 receptor is located pre-junctionally (D 2short ) in dopaminergic nerves; however, post-junctional D 2 receptor (D 2Long ) expression has been described in the heart and arteries (at least in coronary artery) [160] and in opossum kidney cells, a proximal tubule cell line that has some distal tubular cell characteristics [161] . D 2 -like receptors can have vasodilatory/vasconstrictor and natriuretic/antinatriuretic effects [53, 141] that may be related to state of sodium balance or state of renal nerve activity, as discussed above. However, due to the lack of selective D 2 receptor agonists and antagonists, the role of D 2 receptor in hypertension is not clear.
Physiological role of D 2 receptor
Deletion of the Drd2 gene (encoding the D 2 receptor) in mice causes hypertension that may be salt-sensitive [162, 163] . As compared with wild-type mice, renal local dopamine synthesis is reduced in D 2 −/− mice [164] . The activity of AADC, which converts l-DOPA into dopamine, is suppressed in D 2 −/− mice, and is accompanied by lower basal urine flow and sodium excretion. Administration of dopamine can restore urine volume and sodium excretion of D 2 −/− mice to a level similar to that observed in D 2 +/+ mice. These results indicate that D 2 receptors play a significant role in renal local dopamine synthesis and that a decreased renal production of dopamine is, at least in part, responsible for the suppression of urine volume and sodium excretion in D 2 −/− mice [164] .
The mechanisms by which the D 2 receptor regulates sodium reabsorption are not known. Previous studies have shown that D 2 -like receptors, in concert with D 1 -like receptors, inhibit Na + /K + ATPase activity in renal proximal tubules cells and synergistically increase sodium excretion in WKY rats [35, 37, 53] . In LTK2 cells transfected with either rat D 1 or D 2Long cDNA, D 1 -like receptor stimulation decreases Na + /K + ATPase activity, whereas D 2 -like receptor stimulation produces the opposite effect; these effects are transduced by increases or decreases in cAMP production respectively [165, 166] . Stimulation of the D 2 -like receptor by bromocryptine increases Na + /K + ATPase activity [134] ; however, simultaneous activation of D 1 -like and D 2 -like receptors in renal proximal tubule cells decreases Na + /K + ATPase activity and, hence, inhibits sodium transport [141] [142] [143] [144] . Similarly, in the LTK2 cell transfected with both rat D 1 and D 2Long cDNA, D 2 -like agonists enhance the ability of D 1 -like agonists to stimulate cAMP production [167] . In heterologously transfected CHO (Chinesehamster ovary) cells expressing 10 times more D 2 than D 1 receptors, stimulation of either receptor results in a potentiation of arachidonic acid release compared with those cells expressing only one receptor [168, 169] . Arachidonic acid cytochrome P450 products have been shown to inhibit renal sodium transport [170, 171] . Thus D 1 /D 2 receptor synergism in the production of cAMP and arachidonic acid products might account for the D 2 receptor-mediated natriuretic effects.
D 2 receptor and hypertension
Abnormalities in D 2 -like receptor function have been reported in hypertension. Several D 2 receptor polymorphisms have been reported, one of which is associated with hypertension [172, 173] . Transfer of a segment of chromosome 8, containing the Drd2 gene, from the normotensive Brown Norway rat to an SHR background decreases BP [174] . D 2 −/− mice have been used as an alternative genetic approach to solve the problem of the lack of a specific D 2 receptor agonist and antagonist. D 2 −/− mice have increased BP that may or may not be dependent on sodium, depending upon the genetic background [162, 163] . +/+ mice. The enhanced vascular reactivity in the D 2 mutant mice may be caused by increased sympathetic and ET B receptor activities [162] .
The D 2 receptor is expressed in the kidney, but whether or not the kidney plays an important role in the increased BP in D 2 −/− mice is not yet established. In our study [162] , basal Na + /K + ATPase activities in renal cortex and medulla are higher in D 2 +/+ mice than in D 2 −/− mice. Urine flow and sodium excretion are higher in D 2 −/− mice than in D 2 +/+ mice before and after acute saline loading [162] . However, in another study, after a high-salt diet for 8 weeks, BP was found to increase in D 2 −/− mice, but not in D 2 +/+ mice. Calculation of sodium and potassium balance reveals a significantly high level of sodium retention in D 2 −/− mice placed on the high-salt diet [163] . The discrepancy between these two experiments is not known, but it might be due to the different protocols or genetic backgrounds; for example, one is acute salt loading and the other is a chronic highsalt diet for 8 weeks.
D 4 RECEPTOR
The D 4 receptor, cloned in 1991, is a member of the D 2 -like receptor family [175] . It has homology with the D 2 receptor and shares a number of biochemical pathways such as inhibition of adenylate cyclase [176] . D 4 receptors are expressed in the heart and brain nuclei; in the kidney, the D 4 receptor is found in renal collecting ducts, proximal and distal tubules and juxtaglomerular cells, but not in the loop of Henle [177] [178] [179] . In the renal artery, D 4 receptor protein is observed perivascularly in the adventitia and the adventitia/media border; after renal denervation, D 4 receptor expression is abolished [177, 178] . It is possible that the D 4 receptor plays a role in the regulation of BP; however, the lack of highly selective D 4 receptor agonists and antagonists precludes the use of pharmacological studies to assign definitively the role of the D 4 receptor in the regulation of cardiovascular function.
Physiological role of D 4 receptor
The potent natriuretic effect of dopamine in humans and rodents may also be ascribed to stimulation of D 4 receptors. D 4 receptors have been shown to antagonize vasopressin-and aldosterone-dependent water and sodium transport in the cortical collecting duct [180, 181] . However, there are no differences in renal Na + /K + ATPase activity and urinary dopamine excretion between D 4 −/− and D 4 +/+ mice. The D 4 −/− mice do not have an impaired ability to excrete an acute saline load [155] . Nevertheless, it is possible that pressure natriuresis or some other mechanism may have obfuscated any deficit in the renal handling of sodium in D 4 −/− mice [155] .
D 4 receptor and hypertension
To circumvent the difficulty caused by the lack of a highly selective D 4 +/+ littermates. However, the hypotensive effect of losartan dissipates after 10 min in D 4 +/+ mice, whereas the effect persists for > 45 min in D 4 −/− mice. Absence of the D 4 receptor increases BP, in part, by increased AT 1 receptor expression [155] .
Loci near the DRD4 gene (encoding D 4 receptor; 11p15.5) have been linked to human essential hypertension [182, 183] . The most intensively studied D 4 receptor polymorphism is a 48 bp repeat located in exon 3 of the DRD4. This variant codes for a 16-amino-acid sequence located in the third intracellular loop of the D 4 receptor protein, a region that is thought to interact with Gproteins and influence intracellular levels of cAMP [184] . The number of repeats at the D 4 site varies from two to ten, but, in populations of white ethnicity, four and seven repeat lengths are the most common. In this white population, the long variant of the DRD4 gene is associated with a 3 mmHg higher systolic BP and 2 mmHg higher diastolic BP [185] .
CONCLUSIONS
Each of the five dopamine receptor subtypes participates in the regulation of BP by mechanisms specific for the subtype (Table 1) . Some receptors regulate BP by [114] Increased sympathetic activity [116] Increased AT 1 receptor expression [106] hypertension [88] [89] [90] [91] 120 ,121] Antioxidant [104] Increased central oxytocin/V1/non-NMDA/ Increased oxidative stress [104] α-adrenergic receptor activity [116] D 3 receptor Inhibition of sodium transport in kidney [136, 139] Hypertension [124] Impaired inhibition of sodium transport in SHRs Locus of D 3 receptor linked to Inhibition of AT 1 receptor expression [158] and Sodium retention [124] [139] and in hypertensive Dahl salthypertension [152, 153] rennin excretion [124] sensitive rats [147] Vasodilation [36] Impaired vasodilation in SHRs [70] Aberrant interaction with AT 1 receptor [158] D 2 receptor Antagonize AngII [156] Hypertension [162, 163] Receptor polymorphism associated Sodium retention [163] with hypertension [172, 173] Increased activities of α-adrenergic and ET B Locus of D 2 receptor gene linked to receptors [162] hypertension [ 
186] D 4 receptor
Antagonize vasopressin-and aldosteroneHypertension with increased renal AT 1 receptor Locus of D 4 receptor gene linked to dependent water and sodium reabsorption in expression [155] hypertension [182, 183] the cortical collecting duct [180, 181] Receptor polymorphism associated with hypertension [185] influencing the central and/or peripheral nervous system, others regulate epithelial transport and the secretion and receptors of several humoral agents. Abnormalities of dopamine receptors (or their regulation) may be important in the pathogenesis of essential hypertension. A mutation of only one dopamine receptor subtype can cause hypertension. Whether multiple dopamine receptor mutations result in a greater increase in BP remains to be determined.
